糖尿病血液透析患者糖化白蛋白与血红蛋白A1c及死亡率的队列研究
该研究基于日本透析治疗学会队列,纳入84 282例维持性血液透析的糖尿病患者,其中22 441例同时有GA和HbA1c数据,随访1年。结果发现GA与1年死亡率呈线性或J型关联,最低死亡率对应GA 15.6-18.2%;GA预测死亡率的能力优于HbA1c。
要点
- 糖尿病血液透析患者GA与1年死亡率呈线性或J型关联。
- GA 15.6-18.2%和HbA1c 5.8-6.3%对应最低1年死亡率。
- GA预测1年死亡率的能力优于HbA1c。
核心结论
- GA与1年死亡率呈线性或J型关联,最低死亡率在GA 15.6-18.2%。
- GA预测死亡率可能优于HbA1c。
研究设计与样本
- 日本透析治疗学会队列,纳入84 282例维持性血液透析的糖尿病患者。
- 其中22 441例同时有GA和HbA1c,随访1年(2013-14),采用Cox回归计算调整HR和95%可信区间。
主要发现
- 1年死亡率最低见于GA 15.6-18.2%和HbA1c 5.8-6.3%的患者。
- GA与死亡率关联为线性或J型,HbA1c为U型。
- GA <12.5%和GA ≥22.9%的患者调整HR显著升高。
- 该趋势在老年、较高血红蛋白或既往心血管疾病患者中变平。
- GA加入模型较HbA1c加入模型在预测1年死亡率时C统计量、Harrell's C和无类别净重分类改善更好。
临床怎么用
- 在糖尿病血液透析患者中可考虑使用GA评估血糖控制与死亡风险。
- GA目标范围可能以15.6-18.2%为参考,但需结合个体情况。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For glycemic control in diabetic patients on dialysis it was unclear what level of glycated albumin (GA) was associated with the lowest mortality and GA's utility. Accordingly, we examined the difference in association between GA and hemoglobin A1c (HbA1c) with 1-year mortality in a cohort of the Japanese Society for Dialysis Therapy. METHODS: We examined 84 282 patients with prevalent diabetes who were on maintenance hemodialysis (HD) (female 30.3%; mean age 67.3 ± 11.2 years; mean dialysis vintage 6.4 ± 4.5 years). Of them, 22 441 had both GA and HbA1c. We followed these for a year, 2013-14, using Cox regression to calculate adjusted hazard ratios (HRs) and 95% confidence limits for 1-year mortality after adjusting for potential confounders such as baseline age, sex, smoking and diabetes type. RESULTS: One-year mortality was lowest in diabetic HD patients who had GA levels of 15.6-18.2% and HbA1c levels of 5.8-6.3%. The associations were linear or J-shaped for GA and U-shaped for HbA1c. Adjusted HRs were significantly higher in patients with GA <12.5% and GA ≥22.9%. This trend flattened in elderly patients, those with higher hemoglobin or those with prior cardiovascular disease. In addition, the C-statistics, Harrell's C and category-free net reclassification improvement to predict 1-year mortality were better when GA was added to the model than when HbA1c was added. CONCLUSIONS: There was a linear or J-shaped association between GA and 1-year mortality, with the lowest mortality at GA 15.6-18.2%. Furthermore, our analyses suggest the potential superiority of GA over HbA1c in predicting mortality.
引用
- Hoshino J, Hamano T, Abe M, et al. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018. PMID: 29528439. doi:10.1093/ndt/gfy014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。